Navigation Links
Undergoing multiple ACL surgeries allows patients to regain basic function, but not full activity
Date:7/14/2012

This release is also available in Chinese on EurekAlert! Chinese.

BALTIMORE, MD Patients who undergo repeated anterior cruciate ligament (ACL) reconstructions, or repeat revision surgery, are unlikely to return to prior activity levels despite showing basic functional improvement according to research being presented at the American Orthopaedic Society for Sports Medicine's (AOSSM) Annual Meeting today.

"We focused on 15 patients entering at least their third ACL surgery on the same knee, a rarity in the orthopedic community" noted lead author Diane Dahm, MD, orthopaedic surgeon from the Mayo Clinic. "These patients, ranging in age from 18 to 57, all demonstrated a return to basic function based on a collective increase in IKDC scores from pre-operative levels at 59 to post-operative levels at approximately 80."

The IKDC system allows patients to self-evaluate their post-surgery recovery. The focus group included 15 of the 18 known repeat revision surgery cases between 1998 and 2009, with eight males and seven females. All patients examined in this study reported improved outcomes in day-to-day function after a repeat revision surgery, however only 27 percent had returned to their same preoperative activity level at final follow up. Patients with grade III or IV chondral injuries or BMI greater than 28 had worse functional outcomes.

"While the small number of patients in this study is a limitation," commented Dahm, "the procedure is relatively uncommon and this is the largest to-date. Gathering information on these unique patients is an important step toward understanding how people will function after a repeat ACL surgery."

No immediate post-operative complications were noted during the study.


'/>"/>

Contact: Lisa Weisenberger
lisa@aossm.org
847-655-8647
American Orthopaedic Society for Sports Medicine
Source:Eurekalert

Related medicine news :

1. Scientists uncover multiple faces of deadly breast cancer
2. Experimental Pill for Multiple Sclerosis Shows Promise
3. Fish Oil Supplements Wont Help in Multiple Sclerosis: Study
4. Kessler Foundation scientist awarded $554,000 for multiple sclerosis employment research
5. Low-dose whole-body CT finds disease missed on standard imaging for patients with multiple myeloma
6. Multiple thought channels may help brain avoid traffic jams
7. Study shows benefit of new maintenance therapy for multiple myeloma
8. FDA Issues Multiple Sclerosis Drug Alert
9. Pot Might Help Ease Multiple Sclerosis Symptoms
10. Lenalidomide prolongs disease control for multiple myeloma patients after stem cell transplant
11. Multiple sclerosis patients have lower risk of cancer: UBC-VCH research
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:6/24/2016)... , ... June 24, 2016 , ... ... and Scientific Sessions in Dallas that it will receive two significant new grants ... grants came as PHA marked its 25th anniversary by recognizing patients, medical professionals ...
(Date:6/24/2016)... ... 24, 2016 , ... Dr. Amanda Cheng, an orthodontist ... has extensive experience with all areas of orthodontics, including robotic Suresmile technology, ... , Micro-osteoperforation is a revolutionary adjunct to orthodontic treatment. It can be used ...
(Date:6/24/2016)... ... June 24, 2016 , ... Topical BioMedics, Inc, makers of Topricin and MyPainAway Pain ... for a minimum wage raise to $12 an hour by 2020 and then adjusting it ... the lost value of the minimum wage, assure the wage floor does not erode again, ...
(Date:6/24/2016)... , ... June 24, 2016 , ... ... at the Clinical Decision Making in Emergency Medicine conference in Ponte Vedra Beach, ... journal articles published in Emergency Medicine Practice and Pediatric Emergency Medicine ...
(Date:6/24/2016)... ... June 24, 2016 , ... Puradigm® ... Group (TGIG), has initiated cultivation and processing operations at its production facility, and ... Nevada. , Puradigm is the manufacturer of a complete system of proactive air ...
Breaking Medicine News(10 mins):
(Date:6/23/2016)... 2016 Roche (SIX: RO, ROG; OTCQX: RHHBY) ... Elecsys BRAHMS PCT (procalcitonin) assay as a dedicated testing ... With this clearance, Roche is the first IVD company ... for sepsis risk assessment and management. PCT ... PCT levels in blood can aid clinicians in assessing ...
(Date:6/23/2016)... 23, 2016 Research and Markets has ... 52" report to their offering. ... creates a favourable commercial environment for MedImmune to enter. The ... that will serve to drive considerable growth for effective anti-influenza ... to cap sales considerably, but development is still in its ...
(Date:6/23/2016)... INDIANAPOLIS , June 23, 2016 ... Tomorrow,s Leaders Scholarship is any indication, the future is ... online at www.diabetesscholars.org by the Diabetes Scholars ... in the way of academic and community service excellence. ... program since 2012, and continues to advocate for people ...
Breaking Medicine Technology: